TNF-α is also expressed by a broad range of immune cell types during inflammation and is capable of acting on a number of cell types including synergistically with IL-17 to promote activation of synovial fibroblasts and keratinocytes in the skin and joint of patients with RA and psoriasis [43], [44]. Here, IL17A is linked to rheumatoid arthritis.